- Home
- EEX vs LENZ Comparison
EEX vs LENZ Comparison
Compare EEX & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EEX
- LENZ
- Stock Information
- Founded
- EEX 2013
- LENZ 2019
- Country
- EEX United States
- LENZ United States
- Employees
- EEX N/A
- LENZ N/A
- Industry
- EEX Advertising
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- EEX Consumer Discretionary
- LENZ Health Care
- Exchange
- EEX Nasdaq
- LENZ Nasdaq
- Market Cap
- EEX 749.0M
- LENZ 819.1M
- IPO Year
- EEX 2017
- LENZ 2021
- Fundamental
- Price
- EEX $4.70
- LENZ $31.96
- Analyst Decision
- EEX Strong Buy
- LENZ Strong Buy
- Analyst Count
- EEX 2
- LENZ 5
- Target Price
- EEX $7.90
- LENZ $41.80
- AVG Volume (30 Days)
- EEX 104.7K
- LENZ 166.8K
- Earning Date
- EEX 08-06-2025
- LENZ 05-07-2025
- Dividend Yield
- EEX 1.28%
- LENZ N/A
- EPS Growth
- EEX N/A
- LENZ N/A
- EPS
- EEX 0.02
- LENZ N/A
- Revenue
- EEX $413,100,000.00
- LENZ N/A
- Revenue This Year
- EEX $14.85
- LENZ N/A
- Revenue Next Year
- EEX $6.42
- LENZ $536.68
- P/E Ratio
- EEX $190.17
- LENZ N/A
- Revenue Growth
- EEX 4.87
- LENZ N/A
- 52 Week Low
- EEX $3.22
- LENZ $14.90
- 52 Week High
- EEX $6.74
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- EEX 61.19
- LENZ 66.33
- Support Level
- EEX $4.59
- LENZ $28.39
- Resistance Level
- EEX $4.80
- LENZ $30.09
- Average True Range (ATR)
- EEX 0.11
- LENZ 1.56
- MACD
- EEX -0.02
- LENZ 0.16
- Stochastic Oscillator
- EEX 73.75
- LENZ 99.35
About EEX Emerald Holding Inc.
Emerald Holding Inc is an operator of B2B trade shows in the United States. The company is engaged in three complementary business lines; Connections division consists of a collection of B2B trade show franchises and other live events that provide exhibitors opportunities to engage with buyers and expand their brand's awareness in their industry, Content division consists of B2B print publications and digital media products that complement existing trade show properties, and the Commerce division which offers software-as-a-service technology that enables year-round B2B buying and selling through Elastic Suite and Bulletin platforms for use by its customers. Majority of the revenue for the company is generated from its Connections segment.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.